Embla Medical hf (OSSFF) Stock Statistics & Valuation Metrics

Embla Medical hf has a market cap or net worth of $1.94B. The enterprise value is $14.29K.

Embla Medical hf has 428,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Embla Medical hf’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 6.56%.

The current PE Ratio of Embla Medical hf is 18.9. Embla Medical hf’s PEG ratio is ―.

In the last 12 months, Embla Medical hf had revenue of 963.59M and earned 86.47M in profits. Earnings per share was 0.20.

In the last 12 months, operating cash flow was 148.47M and capital expenditures -20.60M, giving a free cash flow of 127.86M billion.

Embla Medical hf pays an annual dividend of $0.022, resulting in a dividend yield of ―

Embla Medical hf upcoming earnings date is Oct 20, 2026, Before Open (Confirmed).

Embla Medical hf as a current ratio of 1.48, with Debt / Equity ratio of 58.00%

In the past 12 months, Embla Medical hf has paid 25.20M in taxes.

Embla Medical hf EV to EBITDA ratio is 13.78, with an EV/FCF ratio of 22.00.

Embla Medical hf has $98.78M in cash and marketable securities with ― in debt, giving a net cash position of -$435.20M billion.

Gross margin is 60.28%, with operating margin of 13.43%, and net profit margin of 8.97%.

The average price target for Embla Medical hf is $6.18, which is 11.43% higher than the current price. The consensus rating is Moderate Buy